AMY SEESE: Open Payments
NPI 1033598016 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 24 payments from 7 companies in 2025. Trend: 2023 $98 · 2024 $428 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $157 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| ABBVIE INC. | 2 | $53 |
| Indivior Inc. | 3 | $50 |
| Braeburn Inc. | 3 | $47 |
| Alkermes, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: CAPLYTA, Auvelity, MAVYRET, SUBLOCADE, BRIXADI, VIVITROL, ABILIFY MAINTENA.
Industry payments across OH — which companies pay providers there.
